The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Cutaneous manifestations in COVID‐19: a first perspective
Abstract
In December 2019, unexplained pneumonia cases were initially reported in Wuhan, China. The pathogen, a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was isolated from lower respiratory tract samples of infected patients, and the resultant disease was termed as Coronavirus Disease 2019 (COVID-19).1 By February 15, COVID-19 has rapidly spread throughout China and across the world, until a pandemic condition was announced by March 11.2 Italy was one of the most involved country, and extraordinary restricted measures were performed. Nonetheless, many health workers were affected, and due to this condition, a strong effort was asked to every physicians and nurses. Dermatologists were involved in first line as well, especially in the triage stations and in the medical wards with positive cases, because of the lack of medical doctors. Suspect of COVID-19 is mainly made on clinical signs (fever, fatigue, dry cough, anorexia, dyspnoea, rhinorrhoea, ageusia, anosmia), on vital parameters (temperature, pulse oximetry saturation) and on radiological settings (X-ray, chest CT scan).3 Laboratory findings could often demonstrate lymphopenia and elevated LDH. Nasopharyngeal and oropharyngeal swab, allowing the virus isolation, confirm the diagnosis. There are no data in the literature so far about skin manifestations in COVID-19. As dermatologists, we tried to analyse the cutaneous involvement in COVID-19 patients hospitalized in the Lecco Hospital, Lombardy, Italy. We visited directly or indirectly (because of the high risk of contagion and the lack of protective masks) 148 positive patients and we tried, where it was possible, to record medical history. No clinical images were performed because of the high risk to infect other patients, introducing a photographic device in a restricted room. Analysing history of recent drug intake, we excluded 60 patients that had used any new medicine in the 15 previous days. From the collected data (88 patients), 18 patients (20.4%) developed cutaneous manifestations. Eight patients developed cutaneous involvement at the onset, 10 patients after the hospitalization. Cutaneous manifestations were erythematous rash (14 patients), widespread urticaria (three patients) and chickenpox-like vesicles (one patient). Trunk was the mainly involved region. Itching was low or absent and usually lesions healed in few days. Apparently, there was not any correlation with disease's severity. Analysing these data, we may speculate that skin manifestations are similar to cutaneous involvement occurring during common viral infections. This is a first report and a first perspective of SARS-CoV-2 cutaneous manifestations. Indisputably, we need more papers to confirm and better understand skin involvement in COVID-19. Additionally, both the awareness of protection and protective facilities, generally lacking in medical departments, are of primary necessity. Transmission of SARS-CoV-2 may occur during an incubation period that may be as long as 14 days.4 Asymptomatic individuals (or individuals within the incubation period) has also been described as possible carriers; however, the extent to which this occurs remains unknown.5 Person-to-person spread is thought to occur mainly via respiratory droplets, resembling the spread of influenza. With droplet transmission, virus released in the respiratory secretions when a person with infection coughs, sneezes or talks can infect another person if it makes direct contact with the mucous membranes; infection can also occur if a person touches an infected surface and then touches his or her eyes, nose or mouth. Currently, we strongly underline that infection prevention and control are urgent and critical due to the lack of specific treatment and heightened risk of spreading during the incubation period.6
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Presumed Asymptomatic Carrier Transmission of COVID-19
Bai, Y., Yao, L., Wei, T., Tian, F., Jin, D.-Y., Chen, L., & Wang, M. (2020) · JAMA · doi:10.1001/jama.2020.2565 · Cited by 4,498
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Rothe, C., Schunk, M., Sothmann, P., Bretzel, G., Froeschl, G., Wallrauch, C., Zimmer, T., Thiel, V., Janke, C., Guggemos, W., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2001468 · Cited by 4,144
F. T. Z. H. O. W. U. N. C. M. A. R. T., Jin, Y.-H., Cai, L., Cheng, Z.-S., Cheng, H., Deng, T., Fan, Y.-P., Fang, C., Huang, D., Huang, L.-Q., et al. (2020) · Military Medical Research · doi:10.1186/s40779-020-0233-6 · Cited by 2,254
SARS-CoV-2 Infection among Travelers Returning from Wuhan, China
Ng, O.-T., Marimuthu, K., Chia, P.-Y., Koh, V., Chiew, C. J., De Wang, L., Young, B. E., Chan, M., Vasoo, S., Ling, L.-M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2003100 · Cited by 130
Gulati, A., Pomeranz, C. L., Qamar, Z., Thomas, S., Frisch, D., George, G., Summer, R. S., DeSimone, J., & Sundaram, B. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.006 · Cited by 127
Roca‐Ginés, J., Torres‐Navarro, I., Sánchez‐Arráez, J., Abril‐Pérez, C., Sabalza-Baztán, O., Pardo-Granell, S., Martínez‐Cózar, V., Estrada, R. B., & Évole‐Buselli, M. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.2340 · Cited by 81
Tao, J., Song, Z., Yang, J., Huang, C., Feng, A., & Man, X. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19011 · Cited by 74
A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals
To, T. M., Viegi, G., Cruz, Á. A., Taborda‐Barata, L., Asher, I., Behera, D., Bennoor, K. S., Boulet, L., Bousquet, J. J., Camargos, P. A. M., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01704-2020 · Cited by 41
Cited by
Extrapulmonary manifestations of COVID-19
Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185
Galván Casas, C., Català, A., Carretero Hernández, G., Rodríguez‐Jiménez, P., Fernández‐Nieto, D., Rodríguez‐Villa Lario, A., Navarro Fernández, I., Ruiz‐Villaverde, R., Falkenhain‐López, D., Llamas Velasco, M., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19163 · Cited by 1,225
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G., Voors, A. A., Osterhaus, A. D., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,081
Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., et al. (2020) · Allergy · doi:10.1111/all.14429 · Cited by 543
Pouletty, M., Borocco, C., Ouldali, N., Caseris, M., Basmaci, R., Lachaume, N., Bensaid, P., Pichard, S., Kouider, H., Morelle, G., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217960 · Cited by 542
Organ-specific manifestations of COVID-19 infection
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., Terpos, E., & Dimopoulos, M. A. (2020) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00648-x · Cited by 502
AI4COVID-19: AI enabled preliminary diagnosis for COVID-19 from cough samples via an app
Imran, A., Posokhova, I., Qureshi, H. N., Masood, U., Riaz, M. S., Ali, K., John, C. N., Hussain, M. I., & Nabeel, M. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100378 · Cited by 621
Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., Forma, A., Karakuła, K., Flieger, W., Portincasa, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061753 · Cited by 453
Freeman, E. E., McMahon, D. E., Lipoff, J. B., Rosenbach, M., Kovarik, C., Desai, S. R., Harp, J., Takeshita, J., French, L. E., Lim, H. W., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.1016 · Cited by 409
Clinical manifestations of COVID-19 in the general population: systematic review
da Rosa Mesquita, R., Francelino Silva Junior, L. C., Santos Santana, F. M., Farias de Oliveira, T., Campos Alcântara, R., Monteiro Arnozo, G., Rodrigues da Silva Filho, E., Galdino dos Santos, A. G., Oliveira da Cunha, E. J., Salgueiro de Aquino, S. H., et al. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01760-4 · Cited by 394
Marzano, A. V., Genovese, G., Fabbrocini, G., Pigatto, P., Monfrecola, G., Piraccini, B. M., Veraldi, S., Rubegni, P., Cusini, M., Caputo, V., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.044 · Cited by 386
COVID-19: Virology, biology and novel laboratory diagnosis
Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3303 · Cited by 371
Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection
Martín Carreras‐Presas, C., Amaro Sánchez, J., López‐Sánchez, A. F., Jané‐Salas, E., & Somacarrera Pérez, M. L. (2021) · Oral Diseases · doi:10.1111/odi.13382 · Cited by 346
Cutaneous manifestations of COVID-19: Report of three cases and a review of literature
Sachdeva, M., Gianotti, R., Shah, M., Bradanini, L., Tosi, D., Veraldi, S., Ziv, M., Leshem, E., & Dodiuk-Gad, R. P. (2020) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2020.04.011 · Cited by 345
Long COVID, a comprehensive systematic scoping review
Akbarialiabad, H., Taghrir, M. H., Abdollahi, A., Ghahramani, N., Kumar, M., Paydar, S., Razani, B., Mwangi, J., Asadi-Pooya, A. A., Malekmakan, L., et al. (2021) · Infection · doi:10.1007/s15010-021-01666-x · Cited by 344
Skin Aging, Cellular Senescence and Natural Polyphenols
Csekes, E., & Račková, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312641 · Cited by 320
Vascular skin symptoms in COVID‐19: a French observational study
Bouaziz, J. D., Duong, T. A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Domergue Than Trong, E., Bagot, M., Begon, E., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16544 · Cited by 311
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
Genovese, G., Moltrasio, C., Berti, E., & Marzano, A. V. (2021) · Dermatology · doi:10.1159/000512932 · Cited by 288
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 281
Extrapulmonary manifestations of COVID-19: Radiologic and clinical overview
Behzad, S., Aghaghazvini, L., Radmard, A. R., & Gholamrezanezhad, A. (2020) · Clinical Imaging · doi:10.1016/j.clinimag.2020.05.013 · Cited by 277
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 258
Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., Fricchione, G. L., & Smith, F. A. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.05.008 · Cited by 199
“While one of these occurred in the context of a chlorpromazine injection at the site, there have been reports of skin manifestations of COVID-19, including petechiae, morbilliform rash, erythematous rash, widespread urticaria, varicella-like vesicles, and pernio-like eruptions [9,10].”
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199
Herpes zoster following inactivated COVID-19 vaccine: a coexistence or coincidence?
Bostan, E., & Yalici‐Armagan, B. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14035 · Cited by 148
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
Thakur, V., Ratho, R. K., Kumar, P., Bhatia, S. K., Bora, I., Mohi, G. K., Saxena, S. K., Devi, M., Yadav, D., & Mehariya, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030446 · Cited by 147
Evidence of SARS-CoV-2 RNA in an oropharyngeal swab specimen, Milan, Italy, early December 2019
Amendola, A., Bianchi, S., Gori, M., Colzani, D., Canuti, M., Borghi, E., Raviglione, M. C., Zuccotti, G. V., & Tanzi, E. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2702.204632 · Cited by 76
“C disease (COVID-19) symptoms can encompass a Kawasaki disease–like multisystem inflammatory syndrome and skin manifestations that accompany common viral infections such as chickenpox and measles (1,2).”
BackgroundMolecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
Hosoki, K., Chakraborty, A., & Sur, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.033 · Cited by 63
Conforti, C., Lallas, A., Argenziano, G., Dianzani, C., Di Meo, N., Giuffrida, R., Kittler, H., Malvehy, J., Marghoob, A. A., Soyer, H. P., et al. (2021) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1101a153 · Cited by 33
Metadata
- Authors
- Recalcati, S.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2020-05
- Volume
- 34
- Issue
- 5
- Pages
- e212-e213
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W3013889157
- Cited by
- 1,348
- References
- 12
- FWCI
- 205.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.